Table 1.
Characteristics | ARC group (n=38) | Control group (n=23) | p | |
---|---|---|---|---|
Sex, n (%) | Female | 11 (28.9) | 8 (34.8) | 0.633 |
Male | 27 (71.1) | 15 (65.2) | ||
| ||||
Age (years) | Median (IQR) | 65.5 (17.7) | 68.0 (12) | 0.421 |
| ||||
Tumor type, n (%) | Cholangiocarcinoma | 2 (5.3) | 0 (0.0) | 0.288 |
Colorectal | 15 (39.5) | 6 (26.1) | ||
HCC | 9 (23.7) | 10 (43.5) | ||
Melanoma | 3 (7.9) | 0 (0.0) | ||
Neuroendocrine | 8 (21.1) | 7 (30.4) | ||
Esophagus | 1 (2.6) | 0 (0.0) | ||
| ||||
No. of lesions per patient | Median (IQR) | 3.0 (2) | 2.0 (4) | 0.421 |
ARC, antireflux catheter; IQR, interquartile range; HCC, hepatocellular carcinoma.
For continuous variables, Mann-Whitney U test was used. For categorical variables, comparisons were made using chi-square test or, when expected counts was low, a Fisher-Freeman-Halton test.